Biotech China 2014

View Profile


Speaking/Presenting-Abstract/Poster at Mtg

Topic Authors / presenters Event name Event date
1. The nuclear translocation of ERK: a novel cancer drug target The First Nancy and Stephen Grand Workshop on Proteomics, Metabolomics and Cancer Drug Discovery, Weizmann Institute of Science, Rehovot, Israel January, 2014
2. Nuclear translocation of MAPKs as a novel target for an anti cancer and anti inflammatory therapies 2013 Mechanisms of Nuclear Transport Meeting, Massachusetts, USA October, 2013
3. MAPK activation as a readout for cellular response to non-ionizing radiation Plenary lecture in the annual BioEM meeting of BEMS Thessaloniki Greece June, 2013
4. The nuclear translocation of MAPKs as a novel target for anti cancer therapy Special lecture in NSW university, Sydney, Australia February, 2013
5. Distinct mechanisms of ERK, JNK, and p38 translocation into the nucleus by importins 3/7/9. International meeting on the Biochemistry, Biology and Pathology of MAP Kinases conference, Maale Hachamisha, Israel October, 2012
6. EMF-induced activation of ERK/MAPK 2012 EMF and Health Risk Research workshop, Monte Verità, Switzerland October, 2012
7. Phosphomimetic mutants of PEDF as anti-angiogenic, anti-cancer drugs 1st Symposium in Angiogenesis, Lymphogenesis and Endothelial Barriers, Sao Paulo Brazil January, 2012
8. Importin 3,7,9-mediated nuclear translocation of MAPKs 2011 Mechanisms of Nuclear Transport Meeting, Maale Hachamisha, Israel November, 2011
9. The NTS of ERK as a target for CK2 phosphorylstion and anti cancer therapy FASEB Summer Research Conference on Protein Kinases and Protein Phosphorylation, Aspen, CO, USA July, 2011
10. The ERK signaling cascade: a relay race on the way to cancer The 26th meeting of the Brazilian Federation of Experimental Biology Societies (FeSBE) Rio De Janeiro, Brazil January, 2011
11. Phospho-mimetic mutants of PEDF as anti-angiogenic, anti-cancer drugs XI Brazilian symposium on extracellular matrix and VI international symposium on extracellular matrix (SIMEC), Búzios Brazil January, 2011
12. The subcellular localization of ERK: Nuclear Translocation Signal (NTS) and importin7 pave the way to the nucleus. Invited lecture at the Oral and Pharyngeal Cancer Branch, the NIH, Bethesda, MD, USA October, 2010
13. Identification and characterization of a general nuclear translocation signal in signaling proteins Invited lecture at the Institute of Cancer (INCA), Rio De Janeiro, Brazil July, 2010
14. The Subcellular Localization of ERK: Nuclear Translocation Signal (NTS) and importin7 pave the way to the Nucleus The 15th meeting of the Brazilian Society for Cell Biology Sao Paolo, Brazil July, 2010
15. Phosphomimetic mutants of PEDF as anti-angiogenic, anti-cancer drugs The 3rd Encontro International de Pathologia Investigativa and the 8th Jordana de Patologia do Hospital, Sao Paulo, Brazil January, 2010
16. The Subcellular Localization of ERK: Nuclear Translocation Signal (NTS) and Importin7 Pave the Way to the Nucleus. FASEB Summer Research Conference on Protein Kinases and Protein Phosphorylation, Aspen CO, USA July, 2009
17. Chairperson of a session on Spacing and Patterning. SPATIAL 2009 - Overcoming distance in signaling networks - Maale HaChamisha, Israel March, 2009
18. The subcellular localization of ERKs and MEKs - NTS and importin7 pave the way to the nucleus. Special division (Faculty) seminar - Imperial College, London, UK February, 2009
19. Gq protein-coupled receptors as apoptosis-inducers: PI3K and AKT inhibition by PP2A leads to JNK activation 21th IUBMB meeting, Shanghai, China January, 2009
20. A nuclear translocation signal (NTS) interaction with importin-7 mediates the nuclear translocation of MAPKs. 2009 Mechanisms of Nuclear Transport Meeting, Banff Canada January, 2009
21. Mechanism of short-term ERK activation by EF at mobile phone frequencies Workshop on “Open Questions in the Research on Biological & Health Effects of Low-Intensity RF-EMF”, Stuttgart, Germany November, 2008
22. Identification of an NTS in signaling molecules. Chairman of the signal transduction session International symposium on signal transduction in health and disease (STADY-V). Tel Aviv, Israel October, 2008
23. Identification of a nuclear translocation signal in signaling molecules Special meeting: System Biology of Cancer, Signaling Networks Modeling & Clinical Implications, Rehovot, Israel September, 2008
24. Identification of a nuclear translocation signal in signaling molecules World Cancer Congress, Shanghai China June, 2008
25. Activation of MAPKs by cellular phone radiation Special meeting: Swiss NRP57 Workshop: " Towards a mechanism-based framework in EMF research", Zurich, Switzerland May, 2008
26. The ERK/MAPK signaling cascade: nuclear shuttling on the way to proliferation FISEB (Ilanit) 2008, the signaling network session. Eilat, Israel January, 2008
27. Cellular signaling: from oncogenic stimulation to nuclear translocation. Plenary lecture in ISCORT (Israeli clinical oncology and radiation therapy conference), Eilat, Israel January, 2008
28. The mechanism of MAPK activation by cellular phone irradiation. Special lecture in the Israeli parliament (Kneset, Jerusalem) September, 2007
29. Identification of a novel nuclear translocation signal (NTS) in signaling proteins Receptor Tyrosine Kinases meeting, Hinxton, England July, 2007
30. A novel nuclear translocation signal (NTS) - a general mechanism for stimulus-dependent nuclear shuttling LSI-Weizmann Institute of Science Joint Symposium, Ann Arbor, MI, USA April, 2007
31. Alternatively spliced forms expend the specificity of the ERK signaling cascade EMBO FEBS/ISF Workshop on System dynamics of intracellular communication. Ma’ale Hachamisha, Israel March, 2007
32. Calcium involvement in activation of ERK5 through Lad-MEKK2 Annual ASBMB meeting, signaling symposium. San Francisco CA April, 2006
33. GnRH-a induced apoptosis of prostate cancer Keynote speaker in the GIF meeting on endocrinology. Ein Bokek, Israel February, 2006
34. A family of alternative spliced forms of ERK1. International symposium on signal transduction in health and disease (STADY-IV). Tel Aviv, Israel October, 2005
35. ERK1b, ERK1c and ERK1d, a family of alternative spliced forms of ERK1 FISEB 2005, the signaling network session. Eilat, Israel February, 2005
36. MAPK signaling in health and disease Plenary lecture in the annual meeting of the Israeli Society of Pathology. Tel Aviv, Israel January, 2005
37. ERK1b, ERK1c and ERK1d, a family of alternative spliced forms of ERK1 Chairman and lecturer in the 7th international symposium on molecular medicine. Crete, Greece October, 2004
38. MAPK signaling in health and disease. Plenary lecture in the annual meeting of the Israeli Society of Nephrology and Hypertension. Zefat, Israel July, 2004
39. Induction of apoptosis in prostate cancer cell lines, role of the PI3K-PKB signaling pathway The joint meeting of the Israeli Societies of Cell Biology and Developmental Biology. Eilat, Israel June, 2003
40. MAPK signaling cascades: regulation by localization Plenary lecture in the annual Korean Biochemical Society meeting. Seoul, Korea May, 2003
41. MAPK signaling cascades: regulation by subcellular localization The 18th Pasteur-Weizmann meeting. Strasburg, France January, 2003
42. Proof of concept of the Kinace technology platform International symposium on signal transduction in health and disease (STADY III). Tel Aviv, Israel October, 2002
43. Protein kinases as therapeutic drug targets International IRA-science talks on therapeutic drug targets. Boston, USA May, 2002
44. ERK1b - a novel ERK isoform with a unique mode of regulation 2nd Korea-Israel joint symposium on biotechnology. Seoul, Korea January, 2002
45. Subcellular localization of kinases in the regulation of signaling cascades Plenary lecture at the departmental day of the Department of Biology. Ben-Gurion University, Beer Sheva, Israel May, 2001
46. The cytoplasmic-nuclear translocation of ERK 25th Anniversary symposium on Hormones and Cell Regulation. Mont Sainte Odile, France September, 2000
47. The subcellular localization of ERK2: implications for the mechanisms of ERK regulation International symposium on signal transduction in health and disease (STADY II). Tel Aviv, Israel September, 2000
48. Activation of MAPKs by GnRH The 17th Pasteur-Weizmann symposium. The Weizmann institute of Science, Israel June, 2000
49. Translocation of ERK into the nucleus. 6th IUBMB meeting. Seoul, Korea October, 1999
50. The role of stress activated protein kinases in G-protein signaling. International meeting on stress proteins. Kwangju, Korea October, 1999
51. Mechanism of Jun kinase and MAP kinase activation by GnRH 17th ISN/ESN joint meeting. Berlin, Germany January, 1999
52. Mechanism of Jun kinase and MAP kinase activation by GnRH Chairman and speaker: the 10th International conference on second messengers & phosphoproteins. Jerusalem, Israel November, 1998
53. Mechanism of Jun kinase and MAP kinase Activation by GnRH. International symposium on signal transduction in health and disease, (STADY I). Tel Aviv, Israel November, 1997
54. Differential activation of MAPK signaling cascades - role in the determination of extracellular signal specificity 7th meeting of the European Neuroendocrine Association. Jerusalem, Israel October, 1995
55. Studying the role of MAPKK using point mutations Special conference: phosphorylation - structural aspects. Rehovot, Israel April, 1994



Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Rony Seger Signalling to and from Endomembranes March, 2014
Intracelular Signaling Pathways – Prof. Rony Seger Sao Paulo Advanced School in Oncogenesis and Translational Medicine (ESPCA) + Bioinformatics (Mini-course) February, 2014

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.